No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
FDA Issues CRL for Alvotech’s Biosimilar Golimumab
On 2 November 2025, Alvotech announced that the FDA has issued a complete response letter (CRL) for Alvotech’s Biologics Licence Application (BLA) for AVT05, biosimilar to J&J’s Simponi® (golimumab) in pre-filled syringe and autoinjector presentations.